DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Is EP Biocomposites Ltd or NTPC Limited a better stock to buy?

EP Biocomposites Ltd (EPBIOCOMPOSITESLTD), NTPC Limited (NTPC) are compared on DocStoX across valuation, profitability, growth and financial health. On P/E: EP Biocomposites Ltd at 12.2, NTPC Limited at 11.3. On ROE: EP Biocomposites Ltd at 12.9%, NTPC Limited at 13.3%. The better pick depends on whether you prioritise valuation, growth or balance-sheet strength.

EP Biocomposites Ltd vs NTPC Limited: which has the lowest PE ratio?

NTPC Limited has the lowest PE ratio — EP Biocomposites Ltd is at 12.2, NTPC Limited is at 11.3. A lower PE can signal a cheaper valuation, though it must be read alongside growth and quality.

Which is bigger, EP Biocomposites Ltd or NTPC Limited?

NTPC Limited is the largest by market capitalisation — EP Biocomposites Ltd is ₹18 crore, NTPC Limited is ₹3,06,899 crore.

EP Biocomposites Ltd vs NTPC Limited

A side-by-side comparison of EP Biocomposites Ltd (EPBIOCOMPOSITESLTD) and NTPC Limited (NTPC) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, NTPC Limited leads EPBIOCOMPOSITESLTD vs NTPC on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation13
Profitability13
Growth20
Size & financial health13

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

NTPC takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

12.20

P/E ratio

11.30

1.48

P/B ratio

1.61

0.00%

Dividend yield

2.69%

₹6.13

EPS

₹27.90

Profitability

NTPC takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

12.90%

Return on equity

13.31%

14.28%

Return on capital

8.63%

14.82%

EBITDA margin

29.50%

8.58%

Net margin

14.70%

Growth

EPBIOCOMPOSITESLTD takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

19.34%

Revenue CAGR (3Y)

2.07%

19.91%

Profit CAGR (3Y)

17.18%

Size & financial health

NTPC takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹18 Cr

Market cap

₹3.07L Cr

₹12 Cr

Revenue

₹1.87L Cr

₹1 Cr

Net profit

₹27,546 Cr

0.20

Debt / equity

1.33

EP Biocomposites Ltd

− ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 12.0% over last 3 years.", "Company has high debtors of 317 days."]

NTPC Limited

+ ["Company has been maintaining a healthy dividend payout of 31.7%"]

− []

EP Biocomposites Ltd full analysis NTPC Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.